168 related articles for article (PubMed ID: 24236632)
21. Varenicline for smoking cessation: a placebo-controlled, randomized study.
Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
[TBL] [Abstract][Full Text] [Related]
22. Outcomes and predictive factors for successful smoking cessation therapy in COPD patients with nicotine dependence.
Hashimoto R; Tomioka H; Wada T; Yoshizumi Y
Respir Investig; 2020 Sep; 58(5):387-394. PubMed ID: 32381453
[TBL] [Abstract][Full Text] [Related]
23. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
[TBL] [Abstract][Full Text] [Related]
24. The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.
Fagerström K; Russ C; Yu CR; Yunis C; Foulds J
Nicotine Tob Res; 2012 Dec; 14(12):1467-73. PubMed ID: 22467778
[TBL] [Abstract][Full Text] [Related]
25. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
[TBL] [Abstract][Full Text] [Related]
27. Reversibility of impaired nasal mucociliary clearance in smokers following a smoking cessation programme.
Ramos EM; De Toledo AC; Xavier RF; Fosco LC; Vieira RP; Ramos D; Jardim JR
Respirology; 2011 Jul; 16(5):849-55. PubMed ID: 21545372
[TBL] [Abstract][Full Text] [Related]
28. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
[TBL] [Abstract][Full Text] [Related]
29. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking.
Chan SS; Leung DY; Abdullah AS; Wong VT; Hedley AJ; Lam TH
Addiction; 2011 Jun; 106(6):1155-63. PubMed ID: 21226883
[TBL] [Abstract][Full Text] [Related]
31. Nicotine gum dependence treated with varenicline--a case report.
Garelik DA
Nicotine Tob Res; 2010 Oct; 12(10):1041-2. PubMed ID: 20829327
[TBL] [Abstract][Full Text] [Related]
32. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
Le Houezec J; Säwe U
J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
[TBL] [Abstract][Full Text] [Related]
33. Smoking cessation intervention: an evidence-based approach.
Laniado-Laborín R
Postgrad Med; 2010 Mar; 122(2):74-82. PubMed ID: 20203458
[TBL] [Abstract][Full Text] [Related]
34. Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
Umene-Nakano W; Yoshimura R; Yoshii C; Hoshuyama T; Hayashi K; Hori H; Katsuki A; Ikenouchi-Sugita A; Nakamura J
Hum Psychopharmacol; 2010 Apr; 25(3):276-9. PubMed ID: 20373480
[TBL] [Abstract][Full Text] [Related]
35. Lung nodule and functional changes in smokers after smoking cessation short-term treatment.
Maci E; Comito F; Frezza AM; Tonini G; Pezzuto A
Cancer Invest; 2014 Oct; 32(8):388-93. PubMed ID: 24941266
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Pulmonary Function Testing on the Success of Smoking Cessation.
Salepci B; Caglayan B; Fidan A; Parmaksiz ET; Kiral N; Comert SS; Dogan C; Coskun E
Respir Care; 2016 Aug; 61(8):1073-80. PubMed ID: 26932380
[TBL] [Abstract][Full Text] [Related]
37. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study.
Kanner RE; Connett JE; Williams DE; Buist AS
Am J Med; 1999 Apr; 106(4):410-6. PubMed ID: 10225243
[TBL] [Abstract][Full Text] [Related]
38. Smoking cessation improves cardiometabolic risk in overweight and obese subjects treated with varenicline and dietary counseling.
Heggen E; Svendsen M; Tonstad S
Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):335-341. PubMed ID: 28216282
[TBL] [Abstract][Full Text] [Related]
39. [Smoking cessation--what's new?].
Reinhardt C; Andreas S
Dtsch Med Wochenschr; 2015 Feb; 140(3):188-90. PubMed ID: 25658406
[No Abstract] [Full Text] [Related]
40. The effects of cigarette smoking and smoking cessation on the carbon monoxide diffusing capacity of the lung in asymptomatic subjects.
Knudson RJ; Kaltenborn WT; Burrows B
Am Rev Respir Dis; 1989 Sep; 140(3):645-51. PubMed ID: 2782738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
